Republicans have made efforts to repeal the ACA since its enactment, but Congress has not yet acted in 2017 to make significant changes to the law. Republicans have circulated multiple plans to replace the law, and Republican leadership has indicated that a replacement plan should reverse the expansion of Medicaid, strengthen Medicare, and give tax
-Zug, Switzerland, Feb. 24, 2017- Auris Medical Holding AG, a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that the US Food and Drug Administration has granted Fast Track designation for AM-111 in the treatment of acute sensorineural hearing loss.
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week- Baebies, a company focused on advancing newborn screening and pediatric testing, announced it has received de novo clearance from the U.S. Food and Drug Administration for SEEKER. "Although these LSDs have FDA approved therapies, this is a significant milestone for the LSD
"In his Condition of the State address, Gov. Branstad asked the legislature to take a comprehensive review of all of our state's boards and commissions to address unnecessary barriers that prevent competition and raise costs on Iowans," said Ben Hammes, Branstad's spokesman, in an email. "Thirty-three percent of Iowa's workforce is licensed the
Dr Reddys Laboratories has been issued with a Form483 after an inspection at its active pharmaceutical ingredient plant in Miryalaguda in Telangana, India. The site was one of several Dr Reddys facilities criticized in a US FDA warning letter published in 2015.. In addition, the FDA said Dr. Reddys had failed to prevent unauthorized access to quali
Feb. 24 The Republican-controlled Congress is set to "easily" repeal the financial backing of the Affordable Care Act next month, U.S. Rep. Blake Farenthold said at a Tea Party meeting Thursday night in Corpus Christi. The fourth term congressman said the financial components of President Barack Obama's landmark healthcare reform will be deconstr
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week The FDA granted EMFLAZA priority review, which is reserved for investigational medicines that may offer major advances in treatment over existing options. "We are pleased to learn that the FDA has approved EMFLAZA," said Pat Furlong, founding President and CEO of Parent Proj
WASHINGTON, Feb. 25 The Food and Drug Administration published the following rule in the Federal Register for approval of New Animal Drug applications and withdrawal of approval of New Animal Drug Applications:. Where applicable, FDA is also withdrawing approval of those parts of the NADAs that pertain to use of these antimicrobial drugs for prod
WASHINGTON, Feb. 25 The Food and Drug Administration published the following rule in the Federal Register for withdrawal of Approval of a New Animal Drug Application:. Sujaya Dessai, Center for Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-5761, firstname.lastname@example.org. Putney, Inc., One Monu
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Research findings on Enzymes and Coenzymes- Aspartic Acid Endopeptidases are discussed in a new report. According to news reporting out of Jeju, South Korea, by NewsRx editors, research stated, "Renin-angiotensin-system blockade is thought to slow renal progression in patient
Global Dialysis Market: Industry Analysis& Outlook 2017-2021- Demographic Factors Contribute to the Growth of Dialysis Market- Research and Markets. By a News Reporter-Staff News Editor at Investment Weekly News Research and Markets has announced the addition of the "Global Dialysis Market: Industry Analysis& Outlook" report to their offering.
Global Weight Loss and Obesity Management Market, by Fitness Equipment (Cardiovascular Training Equipment, Strength Training Equipment, Body Composition Analyzers, Fitness Monitoring Equipment), by Surgical Equipment (Minimally Invasive Surgical Equipment, Non-Invasive Surgical Equipment), by Dietary Supplements, by Services, by Geography Indus
By a News Reporter-Staff News Editor at Journal of Transportation- The rapid pace of innovation in medical devices resulted in an unfortunate side effect of increasing medical device recalls in the second half of 2016, according to the July- Dec. 2016 Recall Industry Spotlight report released by Stericycle ExpertSOLUTIONS. The biannual Industry S
-Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, today is reporting additional data from the dose-escalation phase of its ongoing Phase 1/ 2 clinical trial of intratumoral IMO-2125, an agonist of TLR9 in combination with ipilimumab
Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs announced that the Company today received final approval from the U.S. Food and Drug Administration for the Company`s abbreviated new drug...
Maquet Expands Patent Infringement Lawsuit Against Saphena Medical and Dr. Chin, Adds Claims for False Advertising and Correction of Patent Inventorship. By a News Reporter-Staff News Editor at Marketing Weekly News Maquet Cardiovascular, LLC, a worldwide leader in endoscopic vessel harvesting medical devices, filed an amended complaint against S
Mattress Headquarters, a new mattress& adjustable bed company in Lake Charles, LA opens its doors in Lake Charles, LA 70601. Mattress Headquarters offers mattresses, adjustable beds, power lift chairs, pillows, sheets& more. Donny Reed of Lake Charles, LA& Robert Green of Nederland, TX partner up to bring the Lake Area a new& unique mattress stor
The certified HEDIS measure module leverages MedeAnalytics' investment in Apache SparkTM technology that provides increased performance gains with validated calculations in minutes. "Quality of care will continue to be a primary focus for healthcare, and as one of the earliest recipients of the NCQA certification, MedeAnalytics continues to.
By a News Reporter-Staff News Editor at Investment Weekly News PAVmed Inc., a highly differentiated, multi-product medical device company, announced the closing of a $1.5 million financing. Lishan Aklog, Chairman and CEO of PAVmed, stated, "The strong investor interest in our company has been extremely gratifying. In addition, PAVmed expects to f
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Perrigo Company plc announced that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration for clindamycin, benzoyl peroxide topical gel, the generic version of Onexton gel. Perrigo has notified Valeant Pharmaceuticals North America LLC
By a News Reporter-Staff News Editor at Investment Weekly News Research and Markets has announced the addition of the "Recombinant Drugs to 2020" report to their offering. This report examines FDA and EMA-approved biological drugs and their position and potential in a dozen major disease segments- markets with important implications for drug deve
The accreditation was achieved for using electronic medical records and other supporting technologies to enhance the quality of care provided to patients and families at the Sidra Outpatient Clinic, It said in a press statement Saturday. It puts the Sidra Outpatient Clinic in the same exclusive league as some of the top technologically advanced hos
President Donald Trump and a Republican majority in Congress say they will repeal the Affordable Care Act and replace it in part with a Medicaid block grant plan even conservative Virginia lawmakers fear would punish the state. Congress also must decide by the end of September whether to reauthorize the children's health insurance program that pays
Tenders are invited for Supply of 2 mobile X-ray units with C-arm with flat panel. Short description: The subject of the tender is the supply 2 pcs new, unused and nerepasovanho mobile X-ray C-arm with flat detector and the implementation of the warranty and post service. This contract is divided into lots: no.
Feb. 25 Two shareholders of Clovis Oncology are accusing the Boulder company of regulatory violations during clinical trials for its failed lung cancer drug rocilentinib,. Clovis disclosed the most recent allegations in a 10- K filed Thursday with the Securities and Exchange Commission, calling them "unfounded." The 10- K filing also reported tha